Health Canada Authorizes Pfizer and BioNTech's XFG-Adapted Comirnaty COVID-19 Vaccine for People 6 Months and Older
Pfizer Canada and BioNTech announced on Thursday, September 17, 2026 that Health Canada authorized the XFG variant-adapted Comirnaty vaccine for active immunization against COVID-19 in people aged 6 months and older. The authorization was based on the cumulative clinical, non-clinical, and real-world data the companies had already submitted. The companies said the vaccine will be available through various distribution channels in the coming days and weeks, and Pfizer Canada said it has enough inventory to meet its contractual commitments.